Research Projects on Health and Care

The impact of predictive genetic tests on the insurance industry
08 Apr 2022

Researchers developed a framework for evaluating the potential effects of predictive genetic tests on the UK insurance industry. The framework provides a transparent approach for evaluating whether a specific condition for which a test is available could impact the insurance industry and understanding the key factors that influence this.
The indirect economic and societal burden of seasonal influenza on the UK
29 Mar 2022

In 2019, absenteeism and presenteeism cost the UK economy almost £92 billion because of ill-health, but the economic burden specific to seasonal influenza is not well understood. Researchers are exploring the indirect economic and societal burden of seasonal influenza, including its effects on the UK healthcare system.
The socioeconomic impact of poor indoor climate on health and life satisfaction
22 Mar 2022

Poor indoor climate can result in a higher risk of health and wellbeing disorders, especially in children, the elderly and those with existing health conditions. Exposure of Europeans to damp, mould, and insufficient daylight in residential buildings could cost €53 billion over the next 30 years.
Diagnosis, treatment and management of central diabetes insipidus
07 Mar 2022

RAND Europe was commissioned by Ferring Pharmaceuticals to look at care pathways for patients with CDI. The research focused on identifying the factors that influence the diagnosis, treatment and management of patients with CDI, as well as areas to consider that may improve the quality of care that patients receive, and patient outcomes.
Perspectives on factors most affecting quality of life in Greater Cambridge
01 Mar 2022

Results of a survey and interviews of community stakeholders in the Greater Cambridge area found the factors that most affect quality of life in the region include personal relationships, public transport, and a sense of community.
Evaluating the progress and impacts of the COG-UK consortium
15 Feb 2022

An evaluation of the COVID-19 Genomics UK (COG-UK) consortium finds that it has made a significant and valuable contribution to the UK's public health genomics landscape, but its legacy will depend on decision makers' abilities to maintain momentum, ensure adequate governance, and other factors.
The impact of predictive genetic tests on the insurance industry
03 Feb 2022

Researchers developed a framework for evaluating the potential effects of predictive genetic tests on the UK insurance industry. The framework provides a transparent approach for evaluating whether a specific condition for which a test is available could impact the insurance industry and understanding the key factors that influence this.
Understanding industry contributions to the fight against antimicrobial resistance
01 Feb 2022

The AMR Industry Alliance brings together over 100 biotechnology, diagnostic, generics and research-based biopharmaceutical companies and trade associations in the fight against AMR. RAND Europe assessed the progress of AMRIA members in contributing to tackling AMR and found they are making a difference on diverse fronts.
Assessing the landscape of longitudinal data collection related to gambling
25 Jan 2022

Researchers assessed the feasibility for expanding longitudinal data collection on gambling in the UK. They provide six distinct options, each with their own strengths and drawbacks, for consideration by the charity Action Against Gambling Harms.
The impact of vertical integration of health services
12 Jan 2022

In several locations across England and Wales, NHS organisations responsible for managing acute hospitals have also taken over the running of primary care medical practices. Vertical integration is a valuable option to consider when GP practices look likely to fail due to recruitment and financial difficulties, but it is not an option that should be imposed from the top down.
Evaluating collaborations between primary care general practices in the UK
05 Jan 2022

Primary care networks can help GPs run a wider range of services for their patients and make changes that are needed in response to the COVID-19 pandemic. It will be important to have additional clarification and support around the role of primary care networks in the wider NHS in England.
Smoke-free environments and the advertising of tobacco and related products
04 Jan 2022

Although EU member states are generally compliant with national rules on smoke-free environments and tobacco-related advertising, some areas require closer scrutiny, including protecting children from the harms of smoking.
The impact of respiratory syncytial virus on the NHS, society and economy in the UK
04 Jan 2022

Researchers are carrying out a rapid evidence assessment and modelling and estimating the wider societal and economic burden of RSV in the UK.
Assessing EHR for infectious disease surveillance, prevention and control
10 Dec 2021

Electronic health records (EHR) data could greatly help infectious disease surveillance, but their use varies across Europe. Researchers mapped EHR use to assess the feasibility of using EHR data for infectious disease surveillance.
Assessing POCT for infectious disease surveillance, prevention and control
02 Dec 2021

Researchers examined the availability of point-of-care testing (POCT) devices to diagnose 56 communicable diseases and related health issues under EU surveillance — not including COVID-19 — and mapped trends in the use of POCT in Europe.
Making outcome-based payment a reality in the NHS: Phase 2
23 Nov 2021

To prepare for the implementation of a pilot scheme to pay for cancer drugs based on achieved outcomes, researchers addressed issues identified in the first phase of research, such as the quality and completeness of real-world data on key patient outcomes.
Understanding how rail construction affects mental health and wellbeing
18 Nov 2021

Researchers are exploring how the UK's High-Speed Rail 2 development might affect people who live near the railway line. What they learn will contribute to the design and assessment of later phases of the HS2 scheme.
Reviewing the work and health research landscape
29 Oct 2021

Researchers mapped the funding landscape for work and health research in the UK for the first time. They examined how much has been spent in the area since 2015, what types of research topic are funded and what the priorities for future work and health research should be.
The impact of antimicrobial resistance on modern medicine
30 Sep 2021

Most research on antimicrobial resistance (AMR) focuses on its effects on communicable diseases. But AMR can result in a wide variety of negative outcomes for patients with non-communicable health conditions and/or who are exposed to certain healthcare services.
Communicating research evidence to health and care governance boards
28 Sep 2021

A study of health and care board members in England found that boards engage with research evidence in various capacities when making decisions, but many expressed an appetite for improving the ways and extent to which research evidence is used at the board level.